Vernal keratoconjunctivitis: pathogenesis and treatment.
about
Topical treatments for vernal keratoconjunctivitisAlpha-1 antitrypsin, a diagnostic and prognostic marker of vernal keratoconjunctivitis.Increased incidence of thyroid dysfunction and autoimmunity in patients with vernal keratoconjunctivitis.Identification of human tear fluid biomarkers in vernal keratoconjunctivitis using iTRAQ quantitative proteomics.Sex hormones in allergic conjunctivitis: altered levels of circulating androgens and estrogens in children and adolescents with vernal keratoconjunctivitis.A review of olopatadine for the treatment of ocular allergy.Clinical and biological efficacy of preservative-free NAAGA eye-drops versus levocabastine eye-drops in vernal keratoconjunctivitis patientsOcular safety of cationic emulsion of cyclosporine in an in vitro corneal wound-healing model and an acute in vivo rabbit modelEmerging drugs for ocular allergy.Systematic review and meta-analysis of randomised clinical trials on topical treatments for vernal keratoconjunctivitisOcular complications of severe vernal keratoconjunctivitis (VKC) in Yemen.Allergy and the eye.Nerve growth factor has a modulatory role on human primary fibroblast cultures derived from vernal keratoconjunctivitis-affected conjunctiva.Cellular changes in tears associated with keratoconjunctival responses induced by nasal allergy.Tacrolimus in the treatment of ocular diseases.Ocular allergy: recognizing and diagnosing hypersensitivity disorders of the ocular surface.Use of cyclosporine A and tacrolimus in treatment of vernal keratoconjunctivitis.Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes.Effects of Sex Hormones on Ocular Surface Epithelia: Lessons Learned From Polycystic Ovary Syndrome.Therapeutic effect of 0.1% Tacrolimus Eye Ointment in Allergic Ocular Diseases.Chaperone patterns in vernal keratoconjunctivitis are distinctive of cell and Hsp type and are modified by inflammatory stimuli.The SDF-1α3'A genetic variation is correlated with susceptibility of asthma in Iranian patients.Management of vernal keratoconjunctivitis.Inflammatory mediator profiles in tears accompanying keratoconjunctival responses induced by nasal allergy.Systemic atopy and immunoglobulin deficiency in Turkish patients with vernal keratoconjunctivitis.Long-term use of 0.003% tacrolimus suspension for treatment of vernal keratoconjunctivitis.Prospective, multicenter demographic and epidemiological study on vernal keratoconjunctivitis: a glimpse of ocular surface in Italian population.Impact of Vernal Keratoconjunctivitis on School Children in Egypt.Atopic keratoconjunctivitis with corneal ulcer. Case report.Vitamin D levels in children affected by vernal keratoconjunctivitis.Diagnostic tools in ocular allergy.Tacrolimus vs. cyclosporine eyedrops in severe cyclosporine-resistant vernal keratoconjunctivitis: A randomized, comparative, double-blind, crossover study.The SDF-1 3'A genetic variation is correlated with elevated intra-tumor tissue and circulating concentration of CXCL12 in glial tumors: a study on Iranian anaplastic astrocytoma and glioblastoma multiforme patients.Vernal shield ulcers treated with frequently installed topical cyclosporine 0.05% eyedrops.Recent Updates on Treatment of Ocular Microbial Infections by Stem Cell Therapy: A Review.Surgical debridement plus topical cyclosporine A in the treatment of vernal shield ulcers.[Vernal keratoconjunctivitis].Vascular Endothelial Growth Factor (VEGF) Serological and Lacrimal Signaling in Patients Affected by Vernal Keratoconjunctivitis (VKC)Context-Dependent Regulation of Conjunctival Goblet Cell Function by Allergic Mediators
P2860
Q24198163-D8717C63-3F4D-41FA-BFF2-7B2F22BEA41FQ33839526-2F975CA1-E09C-4579-8A9B-82C5D58C86E3Q34033997-34615016-05C0-4C86-8ADD-8B53D278DE1DQ35065054-8E2623FA-E4D2-47D0-B719-394F6074E81EQ35074600-D3869481-5196-43C1-A12A-EA38459B77F1Q35871885-2986169A-57BC-4A78-9456-905BD2A6FB33Q36172375-9FCD8E59-5DD2-4354-BC53-299BBB476D44Q36182937-B723C4C4-6932-46D4-8490-8474C1AF277AQ36219638-46951BCB-E2BE-419F-8267-6EE9B0ADF39EQ36858637-07B7DD47-6A16-44DA-88F4-9C54F3551B16Q37060000-A3802DE1-05D8-4265-B4C8-9351745569EBQ37249799-F136950B-0789-4645-A294-789D57588090Q37414518-EDEA8009-FFD7-48DD-A673-1571BDD82735Q37697882-1A2B0986-309F-4FA9-B84E-B80D1B9D35AEQ37858514-946A106D-186A-4A2F-8292-48320939F5A1Q38040514-B16ADEF8-0317-46FB-B830-F0B8C7F80C0BQ38102592-0E0C6353-8321-4562-B8AA-E1EEDFE5CBE7Q38179488-1C3ACB19-280A-47CC-B83E-B4B51066F8ADQ38613819-199AF81E-0DC5-40E7-9866-9654D2E911C4Q39168929-761CC9D7-F65A-4C0B-94D1-DE6FFE4EDE60Q40267943-67FC8E7A-F489-41A9-BECF-17B4F2522C6DQ42129392-AD3B568D-45AA-463B-82C6-82849FF3A3FEQ42745061-1CA63413-9635-4F46-AA5D-0B2035649E17Q44681053-E37857BF-C110-4067-B299-B6DBD0B7263DQ46016995-F013ABB7-D604-479A-A7F7-D9CB489E7AE2Q46046521-36723D65-7FAC-45B9-8799-F7127980A95EQ46134688-89F25DB2-E49D-4A45-8B72-CAD6EFB0025EQ46143635-C71339A2-2C56-4D65-B70B-A276DF3B8CEBQ47107858-28F5880A-7EF1-4DC3-AFB1-D0658A2BE845Q47650856-BD92012C-CF2F-474F-B73B-824368D4AAE8Q47896053-8E5A2585-459D-4A88-A362-B2018C95DC4FQ48048235-62FC0CE1-B3EB-424D-B051-1364112C5C6EQ48201727-4213C9E4-6A79-47DA-83CF-19CF4193DAA6Q48315235-B5728F61-20C8-4E3B-A106-DE7D9686189BQ50042214-A2E988D9-38CC-4420-8DD6-991539CBE06AQ50794812-17E062A3-F6DE-424E-9764-5AE34CBD225AQ52870532-7A8399BF-B682-4085-87EA-7D91C32814BBQ57300310-06DAFFB2-EDAD-4163-9C7E-21244A7FFEEFQ58778591-D54CA3EB-AB36-48E8-8071-87137DED5A33
P2860
Vernal keratoconjunctivitis: pathogenesis and treatment.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Vernal keratoconjunctivitis: pathogenesis and treatment.
@ast
Vernal keratoconjunctivitis: pathogenesis and treatment.
@en
Vernal keratoconjunctivitis: pathogenesis and treatment.
@nl
type
label
Vernal keratoconjunctivitis: pathogenesis and treatment.
@ast
Vernal keratoconjunctivitis: pathogenesis and treatment.
@en
Vernal keratoconjunctivitis: pathogenesis and treatment.
@nl
prefLabel
Vernal keratoconjunctivitis: pathogenesis and treatment.
@ast
Vernal keratoconjunctivitis: pathogenesis and treatment.
@en
Vernal keratoconjunctivitis: pathogenesis and treatment.
@nl
P1476
Vernal keratoconjunctivitis: pathogenesis and treatment.
@en
P2093
Andrea Leonardi
P304
P356
10.1016/S1350-9462(02)00006-X
P577
2002-05-01T00:00:00Z